Independence
Magnesa is not a clinic, medical provider, licensed treatment center, or professional body. We keep information separate from commercial promises and personal recommendations.
Magnesa / Independent resource
About
Magnesa is an independent resource on the Stanford-linked magnesium–ibogaine study and the evolving evidence around ibogaine. It helps people understand study design, limitations, safety concerns, and policy context.
Our purpose
Clarity is a form of care.
Magnesa exists for veterans, families, researchers, policymakers, and others seeking clear context on Stanford-linked ibogaine research. The research context gathered across Magnesa is organized to make uncertainty visible rather than to smooth it away.
We are independent by design. We do not provide treatment, referrals, or personal medical guidance. Our role is to offer an orderly starting point for people who want to distinguish a study, a claim, and a decision that requires qualified professional support.
Editorial principles
The standards behind the work.
Evidence before hype
We prioritize primary materials, clear attribution, and the limits attached to any finding. A careful account of what an ibogaine treatment involves should not be confused with an endorsement.
Plain language
We aim to make technical material legible without reducing its complexity. Safety context, uncertainty, and unanswered questions belong beside every plainspoken summary.
Our editorial approach
Sources first. Interpretation second.
Our work begins with registries, published literature, official sources, and the language used in the underlying record. For clinical research, a registry can establish what was planned and how a study was described; ClinicalTrials.gov is one established public reference point for that kind of documentation.
We compare claims against their source, note where evidence is preliminary or incomplete, and avoid treating a single result as a settled conclusion. This approach also helps readers assess how public descriptions of ibogaine clinics in Mexico may differ from independent evidence or regulatory context.
What we cover
A navigable framework, not a verdict.
Magnesa organizes material around study design, evidence limits, safety concerns, and policy context. We present these areas as connected parts of a responsible reading process, with emphasis on the distinction between information and advice.
Where a topic touches regulatory questions, we look to official frameworks rather than assumption. The FDA’s description of drug development and approval provides useful context for why early findings and broader authorization are not interchangeable.
- 01Study record
How a question is framed, what is measured, and what the available materials can support. - 02Evidence limits
What remains uncertain, unmeasured, or outside the scope of a given source. - 03Safety context
Why medical, legal, and practical decisions require expertise beyond an informational resource.
Who this is for
For people looking for a steadier starting point.
Magnesa is intended for people navigating difficult questions without wanting an easy answer. Families may be sorting through conflicting online accounts, researchers may want a concise map of public materials, and policymakers may need a clear distinction between evidence, interpretation, and advocacy.
We recognize that decisions can carry practical pressures. General information about the cost of ibogaine treatment, personal accounts collected through New Path ibogaine reviews, or background on plants associated with ibogaine can raise important questions, but none replaces individualized medical or legal advice.
Independent by design
Information should make the next question clearer.
Magnesa is an independent editorial resource. It does not provide medical or legal advice, and it does not act as a clinic, medical provider, or licensed treatment center. For a concise account of the resource’s structure and scope, visit our public-information approach.
Contact Magnesa